Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b635a0fea6086fbab7eabf27a23cc94c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050700994623e8d5b393c1f8d0d6f7ea |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30 |
filingDate |
2004-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6c0372ccda101028be612fd535ad356 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8afd254d92c6f82f907b6d7b0a67ebbe |
publicationDate |
2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2006034601-A1 |
titleOfInvention |
A new use of medulliadrenal chromaffin cells or peptide functional cells |
abstract |
The invention relates to a new use of Medulliadrenal Chromaffin Cells or Peptide functional cells, especially for preparing a drug for treating or remitting syndromes of abstinence of drug resulting from drug-taking or medicine-abusing. |
priorityDate |
2004-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |